SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934
Date of Report (Date of Earliest Event Reported)
June 15, 2001 (June 14, 2001)
ResMed Inc.
Delaware | 0-26308 | 98-0152841 | ||
(State of | (Commission File Number) | (IRS Employer | ||
Incorporation) | Identification No.) |
14040 Danielson Street, Poway, California 92064-6857
(858) 746-2400
Item 5. Other Events. | ||||||||
Item 7. Exhibits | ||||||||
SIGNATURE | ||||||||
Exhibit Index | ||||||||
EXHIBIT 99.1 | ||||||||
EXHIBIT 99.2 |
Item 5. Other Events.
On June 14, 2001, ResMed Inc. issued a press release announcing it had entered into a purchase agreement providing for the sale to certain initial purchasers of $150 million of convertible subordinated notes (plus an additional $30 million to cover over-allotments, if any).
A copy of the press release is attached as Exhibit 99.1 to this Form 8-K.
On June 15, 2001, ResMed Inc. issued a subsequent press release announcing the specific pricing for the sale of its convertible subordinated notes.
A copy of the press release is attached as Exhibit 99.2 to this Form 8-K.
The notes have not been registered under the Securities Act of 1933 or any state securities laws and may not be offered in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act of 1933 and applicable state securities laws.
Item 7. Exhibits
99.1 | Text of the Press Release, dated June 14, 2001. | ||
99.2 | Text of the Press Release, dated June 15, 2001 |
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: June 15, 2001 |
ResMed Inc. |
By: | /s/ WALTER FLICKER | |
Walter Flicker Corporate Secretary |
Exhibit Index
99.1 | Text of Press Release, dated June 14, 2001 | ||
99.2 | Text of Press Release, dated June 15, 2001 |